Skip to main content

REPROGRAMACION DE CELULAS SOMATICAS DE PACIENTES CON DMAE Y DIFERENCIACION A CELULAS DE EPITELIO PIGMENTARIO PARA SU EDICION GENETICA MEDIANTE LA TECNOLOGIA CRISPR/CAS9

PI18/01536

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2018
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON
Execution centre INSTITUTO DE INVESTIGACION BIOMEDICA DE SALAMANCA (IBSAL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa

  • Sánchez-Cruz, Alonso
  • Hernández-Pinto, Alberto
  • Lillo, Concepción|||0000-0001-5814-9826
  • Isiegas, Carolina
  • Marchena, Miguel
  • Lizasoain, Ignacio
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
  • de la Villa, Pedro|||0000-0001-9856-6616
  • Hernández-Sánchez, Catalina|||0000-0002-0846-5019
  • de la Rosa, Enrique J.|||0000-0001-9984-9706
Synaptic loss, neuronal death, and circuit remodeling are common features of central nervous system neurodegenerative disorders. Retinitis pigmentosa (RP), the leading cause of inherited blindness, is a group of retinal dystrophies characterized by photoreceptor dysfunction and death. The insulin receptor, a key controller of metabolism, also regulates neuronal survival and synaptic formation, maintenance, and activity. Indeed, deficient insulin receptor signaling has been implicated in several brain neurodegenerative pathologies. We present evidence linking impaired insulin receptor signaling with RP. We describe a selective decrease in the levels of the insulin receptor and its downstream effector phospho-S6 in retinal horizontal cell terminals in the rd10 mouse model of RP, as well as aberrant synapses between rod photoreceptors and the postsynaptic terminals of horizontal and bipolar cells. A gene therapy strategy to induce sustained proinsulin, the insulin precursor, production restored retinal insulin receptor signaling, by increasing S6 phosphorylation, without peripheral metabolic consequences. Moreover, proinsulin preserved photoreceptor synaptic connectivity and prolonged visual function in electroretinogram and optomotor tests. These findings point to a disease-modifying role of insulin receptor and support the therapeutic potential of proinsulin in retinitis pigmentosa.